Biopharma Insights - page 15

AI Breaches the Barrier Towards Better CNS Drug Discovery

The Rising Popularity of Antibody-Drug Conjugates, with Challenges

In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant surge in activity: the field of antibody-drug conjugates (ADCs). This …

Continue ›››

Addressing Inequity in Medical Research: The Need to Expand Genomic Databases

Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer to being able to identify the root causes of diseases, develop …

Continue ›››

Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race

Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these technologies a distinct advantage in the tech-enabled pharmaceutical future. One …

Continue ›››

Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators

In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety and efficacy of these potential advancements. Clinical trials, long-drawn, expensive, …

Continue ›››

Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals

The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data available. The requirement for more people to maintain ‘physical distance’ …

Continue ›››

Will Biologics Surpass Small Molecules In The Pharmaceutical Race?

The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked a new era in the pharmaceutical industry. Modern advances in …

Continue ›››

How Lithuania's Deep Tech Ecosystem Is Fueling the Country's Life Sciences Boom

From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears to be a home for a vibrant ecosystem of companies …

Continue ›››

Navigating the UK Health Technology Market: Trends and Opportunities

The UK’s health technology market has seen unprecedented levels of M&A transactions and fundraising. The Covid-19 pandemic acted as a catalyst, accelerating the adoption of digital health solutions, and sparking …

Continue ›››

The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing

As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that is powering this change - Contract Research Organizations (CROs). With …

Continue ›››

AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry

AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with the pharmaceutical and biotech sectors being no exception. It is …

Continue ›››

The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between

Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, up to 90% of the on-the-market therapeutics are small molecules, …

Continue ›››